Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

References for PMC Articles for PubMed (Select 11344269)

1.

The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Jüppner H, Econs MJ.

J Clin Endocrinol Metab. 2001 Feb;86(2):497-500.

PMID:
11157998
2.
3.

Tumor-induced osteomalacia and the regulation of phosphate homeostasis.

Kumar R.

Bone. 2000 Sep;27(3):333-8. Review.

PMID:
10962341
4.

MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.

Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL.

Genomics. 2000 Jul 1;67(1):54-68.

PMID:
10945470
5.

Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.

Fukumoto S, Takeuchi Y, Nagano A, Fujita T.

Bone. 1999 Sep;25(3):375-7.

PMID:
10495143
6.
7.

Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13.

Econs MJ, McEnery PT, Lennon F, Speer MC.

J Clin Invest. 1997 Dec 1;100(11):2653-7.

8.

Biosynthesis, distinct post-translational modifications, and functional characterization of lymphoma proprotein convertase.

van de Loo JW, Creemers JW, Bright NA, Young BD, Roebroek AJ, Van de Ven WJ.

J Biol Chem. 1997 Oct 24;272(43):27116-23.

9.

Dentin matrix protein-1, a candidate gene for dentinogenesis imperfecta.

MacDougall M, Gu TT, Simmons D.

Connect Tissue Res. 1996;35(1-4):267-72.

PMID:
9084665
10.

Characteristics of tumor cell bioactivity in oncogenic osteomalacia.

Nelson AE, Namkung HJ, Patava J, Wilkinson MR, Chang AC, Reddel RR, Robinson BG, Mason RS.

Mol Cell Endocrinol. 1996 Nov 29;124(1-2):17-23.

PMID:
9027320
11.

Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia.

Rowe PS, Ong AC, Cockerill FJ, Goulding JN, Hewison M.

Bone. 1996 Feb;18(2):159-69.

PMID:
8833210
12.

Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.

Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R.

N Engl J Med. 1994 Jun 9;330(23):1645-9. No abstract available.

13.

Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.

Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP.

J Clin Endocrinol Metab. 1995 May;80(5):1628-34.

PMID:
7745010
15.

Renal transplantation in hypophosphatemia with vitamin D-resistant rickets.

Morgan JM, Hawley WL, Chenoweth AI, Retan WJ, Diethelm AG.

Arch Intern Med. 1974 Sep;134(3):549-52. No abstract available.

PMID:
4369139
16.

Tumor measurement in the nude mouse.

Euhus DM, Hudd C, LaRegina MC, Johnson FE.

J Surg Oncol. 1986 Apr;31(4):229-34.

PMID:
3724177
17.

Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice.

Meyer RA Jr, Meyer MH, Gray RW.

J Bone Miner Res. 1989 Aug;4(4):493-500.

PMID:
2816498
18.

Phosphate transport in established renal epithelial cell lines.

Biber J, Malmström K, Reshkin S, Murer H.

Methods Enzymol. 1990;191:494-505. No abstract available.

PMID:
2074775
19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk